| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/04/2004 | EP1386920A1 Benzimidazolone derivatives |
| 02/04/2004 | EP1386908A1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 02/04/2004 | EP1386613A1 Compositions for preparing external carbon dioxide agents |
| 02/04/2004 | EP1386610A1 Medicament containing 2-HETE or 11,12-EET |
| 02/04/2004 | EP1386600A1 Composition gelled with a dextrin ester |
| 02/04/2004 | EP1386279A2 Method for inhibiting metap2 |
| 02/04/2004 | EP1385993A2 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385966A2 Recombinant fusion proteins and the trimers thereof |
| 02/04/2004 | EP1385948A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 02/04/2004 | EP1385883A2 Transmembrane proteins |
| 02/04/2004 | EP1385882A2 Peptides and related molecules that bind to tall-1 |
| 02/04/2004 | EP1385878A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 02/04/2004 | EP1385874A1 Alpha conotoxin peptides with analgesic properties |
| 02/04/2004 | EP1385864A1 Vascular endothelial growth factor 2 |
| 02/04/2004 | EP1385856A2 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
| 02/04/2004 | EP1385854A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 02/04/2004 | EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors |
| 02/04/2004 | EP1385843A1 Arylindenopyridines with pde inhibiting activity |
| 02/04/2004 | EP1385841A1 Sulfonamides |
| 02/04/2004 | EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/04/2004 | EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/04/2004 | EP1385835A1 Benzoxazinone derivatives for use in the treatment of angiogenesis |
| 02/04/2004 | EP1385828A1 Compounds of the family of 3-alkyl-(4,5 dipheny-imidazol-1-yl) and their use as soothing agents |
| 02/04/2004 | EP1385827A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385553A1 Soluble protein-polymer systems for drug delivery |
| 02/04/2004 | EP1385550A2 Therapeutic method for inducing tolerance |
| 02/04/2004 | EP1385527A1 Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof |
| 02/04/2004 | EP1385524A1 Pyrazolopyrimidines as therapeutic agents |
| 02/04/2004 | EP1385519A2 Compounds for treating inflammatory diseases |
| 02/04/2004 | EP1385516A1 The treatment of scarring and related conditions using ppar-gamma activators |
| 02/04/2004 | EP1385505A2 Acne treatment |
| 02/04/2004 | EP1385504A1 Method of inhibiting adhesion formation |
| 02/04/2004 | EP1385500A1 Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 02/04/2004 | EP1385498A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 02/04/2004 | EP1385496A2 Use of compositions for treating rosacea |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1385482A1 An effervescent solid composition of matter |
| 02/04/2004 | EP1257304B1 Foam-forming wound dressing |
| 02/04/2004 | EP1185291B1 Therapeutic agent comprising a botulinum neurotoxin |
| 02/04/2004 | EP1042319B1 Dihydrobenzofurans |
| 02/04/2004 | EP1024784A4 Beta-d glucan topical composition |
| 02/04/2004 | EP0966293B1 Medicine for promoting cicatrization and containing thrombocytes |
| 02/04/2004 | EP0848755B9 Vegf-related protein |
| 02/04/2004 | EP0831838B1 Use of vitamin d 4 derivatives for treating skin disorders |
| 02/04/2004 | EP0789766B1 Chimeric papillomavirus-like particles |
| 02/04/2004 | EP0684816B1 5-ht2 receptor antagonists for treating venous conditions |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473050A Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 02/04/2004 | CN1473048A 1 alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 02/04/2004 | CN1471977A Gene recombined medicine of adenovirus carrier and p53 gene for treating proliferative diseases |
| 02/04/2004 | CN1471940A Reed rhizome sophorae decoction |
| 02/04/2004 | CN1471938A Medicine for treating superficial and deep burn and scald |
| 02/04/2004 | CN1471916A Medicnial composition containing biphenyl lambral for treating superficial mycosis |
| 02/04/2004 | CN1137125C Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 02/04/2004 | CN1137097C Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors |
| 02/04/2004 | CN1136904C Wound plaster of Yunnan Baiyao and its preparing method |
| 02/04/2004 | CN1136898C Burns treating ointment with functions of removing necrosis and promoting granulation |
| 02/04/2004 | CN1136897C Hair generating pill |
| 02/04/2004 | CN1136887C Exterior-applied medicine for treating dermatopathy |
| 02/04/2004 | CN1136884C Diseases-resistant skin-protecting cream |
| 02/04/2004 | CN1136883C Ointment specially for treating dermatosis, preparing method thereof |
| 02/04/2004 | CN1136877C Medicine for treating burn, scald, frost bite and wound, preparing method thereof |
| 02/04/2004 | CN1136871C Traditional Chinese medicine for treating burn and scald and preparation process thereof |
| 02/04/2004 | CN1136865C Wound curing and swelling-eliminating traditional Chinese medicine ointment |
| 02/04/2004 | CN1136859C Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
| 02/04/2004 | CN1136845C 9-cis-visual yellow acid and use of its medicinal salt |
| 02/04/2004 | CN1136839C Quick-acting ointment for treating dermatitis and eczema |
| 02/04/2004 | CN1136836C Body whitening and spicing bath lotion |
| 02/04/2004 | CN1136835C Face-beautifying liniment for eliminating sore from face |
| 02/04/2004 | CN1136833C Biological anti-senility cosmetics |
| 02/04/2004 | CN1136832C Wrinkling modifiers |
| 02/03/2004 | US6686467 Inhibitors of the production of cytokines such as tumour necrosis factor (hereinafter tnf), for example tnf alpha , and various members of the interleukin (hereinafter il) family, for example il-1, il-6 and il-8 |
| 02/03/2004 | US6686388 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 02/03/2004 | US6686386 Combating photoinduced or chronological ageing of skin with retenoic acid receptor agonist |
| 02/03/2004 | US6686382 N-(isoxazolyl)thienylsulfonamides, n-(isoxazolyl)furylsulfonamides, n-(isoxazolyl)pyrrolylsulfonamides and n-(isoxazolyl)phenylsulfonamides; inhibit endothelin |
| 02/03/2004 | US6686378 Derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686351 Compounds and methods for modulation of estrogen receptors |
| 02/03/2004 | US6686347 Phthalazine derivatives for treating inflammatory diseases |
| 02/03/2004 | US6686343 Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine A3 receptor affinitive agents |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |
| 02/03/2004 | US6685950 Methods of treating viral infections |
| 02/03/2004 | US6685924 Conjugate, its preparation and use |
| 02/03/2004 | CA2133086C Skin care method and composition |
| 02/02/2004 | CA2435561A1 Medication to prevent fibroblasts from differentiating to adipocytes |
| 01/29/2004 | WO2004009816A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/29/2004 | WO2004009784A2 Novel inhibitors of kinases |
| 01/29/2004 | WO2004009602A1 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009601A1 Azaindole kinase inhibitors |
| 01/29/2004 | WO2004009600A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/29/2004 | WO2004009596A2 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009592A1 Bicyclic unsaturated tertiary amine compound |
| 01/29/2004 | WO2004009588A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | WO2004009582A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | WO2004009579A1 Novel compounds |
| 01/29/2004 | WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | WO2004009560A1 Novel bio-active molecules |
| 01/29/2004 | WO2004009556A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |